Cardiometabolic and endocrine comorbidities in women with bipolar disorder: A systematic review

Introduction: Bipolar Disorder (BD) is known to be equally distributed among males and females. The welldocumented increased risk of medical comorbidities in patients with BD, in comparison to BD patients without medical comorbidities, shows a negative impact on the course of illness. There is some evidence suggesting that women with BD have higher psychiatric and medical comorbidities in comparison to men with BD, however there is no evidence in comparison to women without BD or other major psychiatric illness. These comorbidities, along with various psychosocial factors, are known to affect the course of BD. Methods: We aimed to systematically review the literature on cardiovascular, metabolic and endocrine comorbidities in women with BD in comparison to men with BD and control women. A comprehensive search of electronic databases including PubMed, PsycINFO, Embase, and SCOPUS was conducted, and a total of 61 identified studies were included in this review. Results: Women with BD had higher rates of cardiovascular risk factors/mortality, diabetes mellitus II and thyroid disorders compared to women in the general population. In comparison to men with BD, women with BD had comparable cardiovascular risk but higher prevalence of metabolic and thyroid disorders. Limitations: Gender specific data was limited in multiple studies. Conclusions: Results present a need for gender-specific screening and interventions for various medical comorbidities in patients with BD.

Automated summary

This systematic review found that women with BD have higher psychiatric and medical comorbidities compared to women without BD or other major psychiatric illness. These comorbidities, along with various psychosocial factors, have been shown to affect the course of BD. Therefore, gender-specific screening and interventions are needed for patients with BD.